Sutro Biopharma (STRO) Total Non-Current Liabilities (2017 - 2026)
Sutro Biopharma (STRO) reported Total Non-Current Liabilities of $296.09 million for Q2 2026, up 1.1% from $292.77 million a year earlier.
Powered by 
Analysis
Sutro Biopharma (STRO) Total Non-Current Liabilities (2017 - 2026) Analysis & Trends
At the end of FY2025, Sutro Biopharma posted Total Non-Current Liabilities of $304.59 million, down 10.7% from FY2024.
- Total Non-Current Liabilities has a five-year compound annual growth rate of 38.1% (FY2020 to FY2025).
- By year, Total Non-Current Liabilities came in at $340.91 million in FY2024 (+6.7%), $319.39 million in FY2023 (+68.3%), $189.78 million in FY2022 (+114.0%) and $88.7 million in FY2021 (+46.1%).
- Five-year quarterly Total Non-Current Liabilities spans a low of $83.16 million in Q1 2022 and a high of $345.55 million in Q1 2025.
- Year over year, Total Non-Current Liabilities gained in three of the last six quarters, with an average decline of 2.4%.
- The high point for year-over-year Total Non-Current Liabilities in five years was Q2 2022 (growth of 261.1%); the low point was Q3 2025 (a decline of 12.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.43 Bn | 1,102.02 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 615.31 Bn | 533.83 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 505.93 Bn | 479.05 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 367.07 Bn | 321.44 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 297.69 Bn | 261.68 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.59 Bn | 235.28 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 236.28 Bn | 191.68 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 190.31 Bn | 164.51 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 170.69 Bn | 117.33 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Sutro Biopharma | 189.91 Mn | -488.59 Mn | - | 296.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 296.09 Mn |
| Dec 31, 2025 | 304.59 Mn |
| Sep 30, 2025 | 295.23 Mn |
| Jun 30, 2025 | 292.77 Mn |
| Mar 31, 2025 | 345.55 Mn |
| Dec 31, 2024 | 340.91 Mn |
| Sep 30, 2024 | 338.92 Mn |
| Jun 30, 2024 | 335.17 Mn |
| Mar 31, 2024 | 303.68 Mn |
| Dec 31, 2023 | 319.39 Mn |
| Dec 31, 2022 | 189.78 Mn |
| Sep 30, 2022 | 170.84 Mn |
| Jun 30, 2022 | 176.42 Mn |
| Mar 31, 2022 | 83.16 Mn |
| Dec 31, 2021 | 88.70 Mn |
| Sep 30, 2021 | 86.39 Mn |
| Jun 30, 2021 | 48.01 Mn |
| Mar 31, 2021 | 48.16 Mn |
| Dec 31, 2020 | 60.24 Mn |
| Sep 30, 2020 | 62.69 Mn |
API Access
Sutro Biopharma Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=STRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "STRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=STRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();